Market Tracker

07/25 7:43am ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.439
Delayed Data
As of Jul 22
 +0.0276 / +6.71%
Today’s Change
0.21
Today|||52-Week Range
0.60
+4.45%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.41
Today’s open0.43
Day’s range0.41 - 0.44
Volume2,895,415
Average volume (3 months)2,492,560
Market cap$84.7M
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
JNPJuniper Pharmaceutic...+0.20+2.67%
ATNMActinium Pharmaceuti...+0.07+4.12%
--Innovative Pharmaceu...+0.00+3.51%
GTXIGTX Inc-0.00-0.02%
Data as of 07/22/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts